News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Susan G. Komen for the Cure Statement on FDA's Decision Removing Genentech (RHHBY)'s Avastin from Approved Breast Cancer Drugs



11/18/2011 10:14:24 AM

DALLAS--(BUSINESS WIRE)--Susan G. Komen for the Cure®, the world’s largest breast cancer organization, issued the following statement today from Komen president Elizabeth Thompson about the U.S. Food and Drug Administration’s decision removing Avastin from the list of approved drugs for the treatment of advanced and metastatic breast cancer:

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES